These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
251 related articles for article (PubMed ID: 33980160)
1. TREM2 promotes natural killer cell development in CD3 Lee HY; Lee EH; Yi J; Ji KY; Kim SM; Choi HR; Yee SM; Kang HS; Kim EM BMC Immunol; 2021 May; 22(1):30. PubMed ID: 33980160 [TBL] [Abstract][Full Text] [Related]
2. Triggering receptor expressed on myeloid cells 2 (TREM2) promotes adipogenesis and diet-induced obesity. Park M; Yi JW; Kim EM; Yoon IJ; Lee EH; Lee HY; Ji KY; Lee KH; Jang JH; Oh SS; Yun CH; Kim SH; Lee KM; Song MG; Kim DH; Kang HS Diabetes; 2015 Jan; 64(1):117-27. PubMed ID: 25114293 [TBL] [Abstract][Full Text] [Related]
3. Axl signaling induces development of natural killer cells in vitro and in vivo. Kim EM; Lee EH; Lee HY; Choi HR; Ji KY; Kim SM; Kim KD; Kang HS Protoplasma; 2017 Mar; 254(2):1091-1101. PubMed ID: 27549806 [TBL] [Abstract][Full Text] [Related]
4. Impairment of hepatic NK cell development in IFN-γ deficient mice. Wu X; Chen Y; Sun R; Wei H; Tian Z Cytokine; 2012 Dec; 60(3):616-25. PubMed ID: 22921904 [TBL] [Abstract][Full Text] [Related]
5. TREM2 macrophages drive NK cell paucity and dysfunction in lung cancer. Park MD; Reyes-Torres I; LeBerichel J; Hamon P; LaMarche NM; Hegde S; Belabed M; Troncoso L; Grout JA; Magen A; Humblin E; Nair A; Molgora M; Hou J; Newman JH; Farkas AM; Leader AM; Dawson T; D'Souza D; Hamel S; Sanchez-Paulete AR; Maier B; Bhardwaj N; Martin JC; Kamphorst AO; Kenigsberg E; Casanova-Acebes M; Horowitz A; Brown BD; De Andrade LF; Colonna M; Marron TU; Merad M Nat Immunol; 2023 May; 24(5):792-801. PubMed ID: 37081148 [TBL] [Abstract][Full Text] [Related]
6. The Effect of Triggering Receptor Expressed by Myeloid Cells 2 Modified Bone Marrow Mesenchymal Stem Cells on Alzheimer's Disease-Mouse Model. Yang Y; Wu X; Qu X; Wang X; Luo C; Li L; Zhang K Ann Clin Lab Sci; 2019 Jan; 49(1):23-30. PubMed ID: 30814074 [TBL] [Abstract][Full Text] [Related]
7. Triggering Receptor Expressed on Myeloid Cells 2 (TREM2) R47H Variant Causes Distinct Age- and Sex-Dependent Musculoskeletal Alterations in Mice. Essex AL; Huot JR; Deosthale P; Wagner A; Figueras J; Davis A; Damrath J; Pin F; Wallace J; Bonetto A; Plotkin LI J Bone Miner Res; 2022 Jul; 37(7):1366-1381. PubMed ID: 35575023 [TBL] [Abstract][Full Text] [Related]
8. Continuous engagement of a self-specific activation receptor induces NK cell tolerance. Tripathy SK; Keyel PA; Yang L; Pingel JT; Cheng TP; Schneeberger A; Yokoyama WM J Exp Med; 2008 Aug; 205(8):1829-41. PubMed ID: 18606857 [TBL] [Abstract][Full Text] [Related]
9. Natural killing of MHC class I(-) lymphoblasts by NK cells from long-term bone marrow culture requires effector cell expression of Ly49 receptors. Lindberg J; Martín-Fontecha A; Höglund P Int Immunol; 1999 Aug; 11(8):1239-46. PubMed ID: 10421781 [TBL] [Abstract][Full Text] [Related]
10. Enhancement of antitumor natural killer cell activation by orally administered Spirulina extract in mice. Akao Y; Ebihara T; Masuda H; Saeki Y; Akazawa T; Hazeki K; Hazeki O; Matsumoto M; Seya T Cancer Sci; 2009 Aug; 100(8):1494-501. PubMed ID: 19432881 [TBL] [Abstract][Full Text] [Related]
11. Unique receptor repertoire in mouse uterine NK cells. Yadi H; Burke S; Madeja Z; Hemberger M; Moffett A; Colucci F J Immunol; 2008 Nov; 181(9):6140-7. PubMed ID: 18941204 [TBL] [Abstract][Full Text] [Related]
12. Triggering receptor expressed on myeloid cells 2 activation downregulates toll-like receptor 4 expression and ameliorates cognitive impairment in the Aβ Qin Z; Gu M; Zhou J; Zhang W; Zhao N; Lü Y; Yu W Synapse; 2020 Oct; 74(10):e22161. PubMed ID: 32412103 [TBL] [Abstract][Full Text] [Related]
13. Clonal acquisition of inhibitory Ly49 receptors on developing NK cells is successively restricted and regulated by stromal class I MHC. Roth C; Carlyle JR; Takizawa H; Raulet DH Immunity; 2000 Jul; 13(1):143-53. PubMed ID: 10933402 [TBL] [Abstract][Full Text] [Related]
14. TREM2 Modulation Remodels the Tumor Myeloid Landscape Enhancing Anti-PD-1 Immunotherapy. Molgora M; Esaulova E; Vermi W; Hou J; Chen Y; Luo J; Brioschi S; Bugatti M; Omodei AS; Ricci B; Fronick C; Panda SK; Takeuchi Y; Gubin MM; Faccio R; Cella M; Gilfillan S; Unanue ER; Artyomov MN; Schreiber RD; Colonna M Cell; 2020 Aug; 182(4):886-900.e17. PubMed ID: 32783918 [TBL] [Abstract][Full Text] [Related]
15. Dual induction of TREM2 and tolerance-related transcript, Tmem176b, in amyloid transgenic mice: implications for vaccine-based therapies for Alzheimer's disease. Melchior B; Garcia AE; Hsiung BK; Lo KM; Doose JM; Thrash JC; Stalder AK; Staufenbiel M; Neumann H; Carson MJ ASN Neuro; 2010 Jul; 2(3):e00037. PubMed ID: 20640189 [TBL] [Abstract][Full Text] [Related]
16. Identification, activation, and selective in vivo ablation of mouse NK cells via NKp46. Walzer T; Bléry M; Chaix J; Fuseri N; Chasson L; Robbins SH; Jaeger S; André P; Gauthier L; Daniel L; Chemin K; Morel Y; Dalod M; Imbert J; Pierres M; Moretta A; Romagné F; Vivier E Proc Natl Acad Sci U S A; 2007 Feb; 104(9):3384-9. PubMed ID: 17360655 [TBL] [Abstract][Full Text] [Related]
17. TREM2 Promotes Microglial Survival by Activating Wnt/β-Catenin Pathway. Zheng H; Jia L; Liu CC; Rong Z; Zhong L; Yang L; Chen XF; Fryer JD; Wang X; Zhang YW; Xu H; Bu G J Neurosci; 2017 Feb; 37(7):1772-1784. PubMed ID: 28077724 [TBL] [Abstract][Full Text] [Related]
18. NCRs and DNAM-1 mediate NK cell recognition and lysis of human and mouse melanoma cell lines in vitro and in vivo. Lakshmikanth T; Burke S; Ali TH; Kimpfler S; Ursini F; Ruggeri L; Capanni M; Umansky V; Paschen A; Sucker A; Pende D; Groh V; Biassoni R; Höglund P; Kato M; Shibuya K; Schadendorf D; Anichini A; Ferrone S; Velardi A; Kärre K; Shibuya A; Carbone E; Colucci F J Clin Invest; 2009 May; 119(5):1251-63. PubMed ID: 19349689 [TBL] [Abstract][Full Text] [Related]
19. Formaldehyde exposure impairs the function and differentiation of NK cells. Kim EM; Lee HY; Lee EH; Lee KM; Park M; Ji KY; Jang JH; Jeong YH; Lee KH; Yoon IJ; Kim SM; Jeong MJ; Kim KD; Kang HS Toxicol Lett; 2013 Nov; 223(2):154-61. PubMed ID: 24060340 [TBL] [Abstract][Full Text] [Related]
20. Characterization of natural killer and natural killer-like T cells derived from ex vivo expanded and activated cord blood mononuclear cells: implications for adoptive cellular immunotherapy. Ayello J; van de Ven C; Cairo E; Hochberg J; Baxi L; Satwani P; Cairo MS Exp Hematol; 2009 Oct; 37(10):1216-29. PubMed ID: 19638292 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]